Table 3.
Treatment and tumor stage of colorectal cancer patients
| SRCC (n = 18) | Non-SRCC (n = 72) | p-value | |
|---|---|---|---|
| Treatment | |||
| Operation | 2 (11.1) | 37 (51.4) | 0.001 |
| Op + C/T | 4 (22.2) | 20 (27.8) | |
| Op + C/T + Target | 10 (55.6) | 11 (15.3) | |
| Op + CCRT | 2 (11.1) | 4 (5.6) | |
| T | 0.002 | ||
| Tis | 1 (5.6) | 0 | |
| 1 | 0 | 4 (5.6) | |
| 2 | 0 | 22 (30.5) | |
| 3 | 8 (44.4) | 36 (50) | |
| 4 | 9 (50) | 10 (13.9) | |
| N | < 0.001 | ||
| 0 | 2 (11.1) | 44 (61.1) | |
| 1 | 2 (11.1) | 21 (29.2) | |
| 2 | 14 (77.8) | 7 (9.7) | |
| M | 0.002 | ||
| 0 | 9 (50) | 62 (86.1) | |
| 1 | 9 (50) | 10 (13.9) | |
| Stage | 0.001 | ||
| 0 | 1 (5.6) | 0 | |
| 1 | 0 | 23 (31.9) | |
| 2 | 1 (5.6) | 20 (27.8) | |
| 3 | 9 (50) | 18 (25) | |
| 4 | 7 (38.8) | 11 (15.3) | |
| Follow-up duration, mean (months) | 15 | 94.5 | < 0.001 |
Chi-square statistic was used for categorical variables among the two cohorts
Op, operation; CT, Chemotherapy; CCRT, concurrent chemoradiotherapy